Weiwei Xie

895 total citations
37 papers, 628 citations indexed

About

Weiwei Xie is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Epidemiology. According to data from OpenAlex, Weiwei Xie has authored 37 papers receiving a total of 628 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 9 papers in Molecular Biology and 9 papers in Epidemiology. Recurrent topics in Weiwei Xie's work include Traditional Chinese Medicine Analysis (4 papers), Cerebrovascular and Carotid Artery Diseases (4 papers) and Acute Ischemic Stroke Management (4 papers). Weiwei Xie is often cited by papers focused on Traditional Chinese Medicine Analysis (4 papers), Cerebrovascular and Carotid Artery Diseases (4 papers) and Acute Ischemic Stroke Management (4 papers). Weiwei Xie collaborates with scholars based in China, United States and United Kingdom. Weiwei Xie's co-authors include Min Liu, Fengjin Guo, Wei Zheng, Rui Luo, Zhengyi Luo, Zhiqiang Liu, Yawovi Souley Agbodjan, Nan Xie, Sheng Yang and Jiaxing Liu and has published in prestigious journals such as Angewandte Chemie International Edition, Blood and Journal of Neurochemistry.

In The Last Decade

Weiwei Xie

31 papers receiving 620 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weiwei Xie China 14 153 140 112 106 60 37 628
Xiaogang Guo China 21 370 2.4× 115 0.8× 120 1.1× 100 0.9× 66 1.1× 133 1.3k
Jianxin Tan China 15 349 2.3× 50 0.4× 201 1.8× 85 0.8× 52 0.9× 68 984
Teng Huang China 14 157 1.0× 38 0.3× 91 0.8× 39 0.4× 60 1.0× 32 635
Xiaoning Kang China 16 223 1.5× 29 0.2× 34 0.3× 52 0.5× 74 1.2× 70 814
Ming-Yang Lee Taiwan 17 222 1.5× 101 0.7× 43 0.4× 30 0.3× 173 2.9× 39 812
Hidekazu Kondo Japan 18 241 1.6× 56 0.4× 53 0.5× 59 0.6× 15 0.3× 79 1.0k
Wei Yu China 15 442 2.9× 58 0.4× 37 0.3× 111 1.0× 72 1.2× 86 976
Tianxiang Wang China 15 141 0.9× 32 0.2× 20 0.2× 51 0.5× 39 0.7× 53 494
Mingwei Zhong China 15 335 2.2× 101 0.7× 64 0.6× 72 0.7× 115 1.9× 57 800

Countries citing papers authored by Weiwei Xie

Since Specialization
Citations

This map shows the geographic impact of Weiwei Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei Xie more than expected).

Fields of papers citing papers by Weiwei Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiwei Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei Xie. The network helps show where Weiwei Xie may publish in the future.

Co-authorship network of co-authors of Weiwei Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Weiwei Xie. A scholar is included among the top collaborators of Weiwei Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiwei Xie. Weiwei Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Xiaoqian, Weiwei Xie, Yujia Yin, et al.. (2025). DUSP4 inhibited tumor cell proliferation by downregulating glycolysis via p-ERK/p-PGK1 signaling in ovarian cancer. Cancer Cell International. 25(1). 87–87. 1 indexed citations
2.
3.
Ni, Youxuan, Yong Lü, Weiwei Xie, et al.. (2025). Dual Active Site Covalent Organic Framework Anode Enables Stable Aqueous Proton Batteries. Angewandte Chemie International Edition. 64(14). e202424025–e202424025. 13 indexed citations
4.
Xie, Weiwei, Yingran Liang, Xiaonan Chen, et al.. (2025). Identification of Lauric Acid as a Potent Sodium Channel NaV1.5 Blocker from Compound Chinese Medicine Wenxin Keli. Drug Design Development and Therapy. Volume 19. 141–157.
5.
Xie, Weiwei, et al.. (2024). Metformin attenuates white matter injury in neonatal mice through activating NRF2/HO-1/NF-κB pathway. International Immunopharmacology. 141. 112961–112961. 2 indexed citations
6.
Xie, Weiwei, Li Di, Peijun Li, et al.. (2024). L ‐ascorbyl‐2‐phosphate alleviates white matter injury caused by chronic hypoxia through the PRMT5 / P53 / NF‐κB pathway. Journal of Neurochemistry. 168(2). 142–160. 2 indexed citations
7.
He, Yulan, Yuan Yang, Ting Liao, et al.. (2024). Effects of mesenchymal stem cells on ovarian sirtuin 1 and caspase-3 in premature ovarian insufficiency mice. ScienceAsia. 50(5). 1–1.
8.
Zhang, Xiaoqian, Xiaocui Zheng, Ying Xiang, et al.. (2023). CEBPG suppresses ferroptosis through transcriptional control of SLC7A11 in ovarian cancer. Journal of Translational Medicine. 21(1). 334–334. 23 indexed citations
9.
Xie, Weiwei, et al.. (2022). Clinical Characteristics and Prognosis of Multiple Myeloma With Myelomatous Pleural Effusion: A Retrospective Single-Center Study. Technology in Cancer Research & Treatment. 21. 2213874258–2213874258. 4 indexed citations
10.
Li, Zhongwen, Hongyun Chen, Xiaomei Yu, et al.. (2022). Artificial intelligence to detect malignant eyelid tumors from photographic images. npj Digital Medicine. 5(1). 23–23. 28 indexed citations
11.
12.
Wang, Taiyi, Weiwei Xie, Jiahui Yu, et al.. (2019). Ion Channel Targeted Mechanisms of Anti-arrhythmic Chinese Herbal Medicine Xin Su Ning. Frontiers in Pharmacology. 10. 70–70. 8 indexed citations
13.
Zheng, Wei, et al.. (2019). ATG5 and ATG7 induced autophagy interplays with UPR via PERK signaling. Cell Communication and Signaling. 17(1). 42–42. 131 indexed citations
14.
Luo, Zhengyi, Sheng Yang, Nan Xie, et al.. (2019). Multi-objective capacity optimization of a distributed energy system considering economy, environment and energy. Energy Conversion and Management. 200. 112081–112081. 138 indexed citations
15.
Wang, Taiyi, Weiwei Xie, Shuang He, et al.. (2019). Clinical evidence-guided network pharmacology analysis reveals a critical contribution of β1-adrenoreceptor upregulation to bradycardia alleviation by Shenxian-Shengmai. BMC Complementary and Alternative Medicine. 19(1). 357–357. 13 indexed citations
16.
Xie, Weiwei, et al.. (2018). Successful fluconazole treatment of catheter-related candidemia caused by Candida haemulonii: report of 2 neonatal cases. Archivos Argentinos de Pediatria. 116(5). e663–e666. 2 indexed citations
17.
Wang, Taiyi, Peng Zhang, Xiaonan Chen, et al.. (2017). An integrated anti-arrhythmic target network of a Chinese medicine compound, Wenxin Keli, revealed by combined machine learning and molecular pathway analysis. Molecular BioSystems. 13(5). 1018–1030. 16 indexed citations
18.
Zhang, Lin, Weiwei Xie, Renrong Wu, et al.. (2015). Case-control association study of ABCB1 gene and major depressive disorder in a local Chinese Han population. Neuropsychiatric Disease and Treatment. 11. 1967–1967. 14 indexed citations
19.
Xie, Weiwei, Lehua Li, Gang Wang, et al.. (2014). Efficacy and Safety of Prolonged-Release Trazodone in Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Flexible-Dose Trial. Pharmacology. 94(5-6). 199–206. 14 indexed citations
20.
Ma, Lintao, et al.. (2008). A Hybrid Feature Selection Algorithm: Combination of Symmetrical Uncertainty and Genetic Algorithms. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaogang Guo Breakdown of academic impact, for papers by Jianxin Tan Breakdown of academic impact, for papers by Teng Huang Breakdown of academic impact, for papers by Xiaoning Kang Breakdown of academic impact, for papers by Ming-Yang Lee Breakdown of academic impact, for papers by Hidekazu Kondo Breakdown of academic impact, for papers by Wei Yu Breakdown of academic impact, for papers by Tianxiang Wang Breakdown of academic impact, for papers by Mingwei Zhong
Rankless by CCL
2026